• Explore /
  • Poster
  • / Liver metastases as predictors of outcome in renal cell carcinoma (RCC) patients (pts) treated with first-line sunitinib (SU) and sorafenib (SO).

Liver metastases as predictors of outcome in renal cell carcinoma (RCC) patients (pts) treated with first-line sunitinib (SU) and sorafenib (SO).

Abstract Poster

Authors

null

Paolo Grassi

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

Paolo Grassi , Elena Verzoni , Luca Porcu , Isabella Testa , Roberto Iacovelli , Enrico Garanzini , Roberto Salvioni , Filippo G. De Braud , Giuseppe Procopio

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Renal Cancer

Track

Renal Cell Cancer

Sub Track

Renal Cell Cancer

Citation

J Clin Oncol 32, 2014 (suppl 4; abstr 536)

DOI

10.1200/jco.2014.32.4_suppl.536

Abstract #

536

Poster Bd #

J13

Abstract Disclosures

Similar Posters

First Author: Camila Nassif Martins Ferreira

Poster

2018 Genitourinary Cancers Symposium

Optimizing axitinib treatment selection following first-line sunitinib in metastatic renal cell carcinoma.

Optimizing axitinib treatment selection following first-line sunitinib in metastatic renal cell carcinoma.

First Author: Sergio Bracarda

First Author: Thomas Cosgriff

First Author: Paolo Grassi